VNDA · NASDAQ · Biotechnology

Vanda Pharmaceuticals (VNDA)

Develops and commercializes specialty therapies across psychiatric, sleep, MS, and motion-sickness markets.

$5.24
After-hours close+0.03 (+0.59%)
At close$5.21(+1.07%)